Fentanyl and Fosrenol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fentanyl (fentanyl citrate) and Fosrenol (lanthanum carbonate). Common drug interactions include anaemia among females and respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Fentanyl and Fosrenol. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Fentanyl?

Fentanyl has active ingredients of fentanyl citrate. It is often used in pain. eHealthMe is studying from 73,301 Fentanyl users. Check the latest studies of Fentanyl.

What is Fosrenol?

Fosrenol has active ingredients of lanthanum carbonate. eHealthMe is studying from 5,922 Fosrenol users. Check the latest studies of Fosrenol.

On Jul, 15, 2026

32 people who take Fentanyl and Fosrenol together, and have interactions are studied.

Fentanyl and Fosrenol drug interactions.

What are the common drug interactions of Fentanyl and Fosrenol, by gender? *:

female:

Anaemia (lack of blood)
Anastomotic complication (complication of surgical connection between two structures)
Asthenia (weakness)
Death
Deformity (disfigurement)
Depressed mood
Depression
Diarrhoea
Dry skin
Dyspnoea (difficult or laboured respiration)

male:

Respiratory failure (inadequate gas exchange by the respiratory system)
Septic shock (shock due to blood infection)
Cellulitis (infection under the skin)
Haemorrhage (bleeding)
Heparin-induced thrombocytopenia
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Nausea (feeling of having an urge to vomit)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pruritus (severe itching of the skin)
Renal failure chronic (long lasting kidney dysfunction)

What are the common drug interactions of Fentanyl and Fosrenol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Heart rate increased
Infection
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
Somnolence (a state of near-sleep, a strong desire for sleep)
Transaminases increased

20-29:

n/a

30-39:

n/a

40-49:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Blood creatinine increased
Complications of transplanted kidney
Depression
Diarrhoea
Dizziness
Dry skin
Dysstasia (difficulty in standing)
Gait disturbance
Haematuria (presence of blood in urine)

50-59:

Fear
Gastrointestinal pain
Neoplasm malignant (cancer tumour)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Death
Injury
Renal failure (kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Depression

60+:

Somnolence (a state of near-sleep, a strong desire for sleep)
Transaminases increased
Sepsis (a severe blood infection that can lead to organ failure and death)
Acidosis (build-up of carbon dioxide in the blood)
Acute myocardial infarction (acute heart attack)
Cellulitis (infection under the skin)
Dizziness
Haemorrhage (bleeding)
Heparin-induced thrombocytopenia
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

What are the existing conditions these people have? *

High Blood Pressure: 13 people, 40.62%
Nausea (feeling of having an urge to vomit): 7 people, 21.88%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 6 people, 18.75%
Acute Kidney Failure: 6 people, 18.75%
Osteoporosis (bones weak and more likely to break): 6 people, 18.75%
Restless Leg Syndrome (a powerful urge to move your legs): 6 people, 18.75%
Dyslipidaemia (abnormal amount of lipids): 5 people, 15.62%
Insomnia (sleeplessness): 4 people, 12.50%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 4 people, 12.50%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 4 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Fentanyl and Fosrenol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously